A HEALTHY DIET AND EXERCISE ARE IMPORTANT. COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE AND SHOULD NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE.

This Medical Device must be applied by a healthcare professional. Always read and follow the instructions. The CoolSculpting® procedure is not for everyone. Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinaemia, cold agglutinin disease or paroxysmal cold haemoglobinuria. Be careful using CoolSculpting® in pregnant or breastfeeding women, in patients who are sensitive to cold or to fructose, glycerin, isopropyl alcohol or propylene glycol; in patients with poor circulation, recent surgery, scar tissue, skin conditions such as eczema, dermatitis, or rashes in the area to be treated, nerve pain following shingles, nerve damage due to diabetes, poor skin sensation, open or infected wounds, bleeding disorders or use of blood thinners hernia in or near the area to be treated; and in patients with implanted pacemakers and defibrillators. The device is not intended to cause weight loss or to treat obesity.

During the procedure patients may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations subside as the area becomes numb. Following the procedure, typical side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. The following rare and very rare side effects have the following reported rates (approximate occurrences per number of treatments): paradoxical hyperplasia (1/3000 [0.033%]); late-onset pain (1/6000 [0.017%]); severe pain (1/6000 [0.017 %]); hyperpigmentation (1/11000 [0.009%]); freeze burn (1/15000 [0.007%]); treatment area demarcation (1/20000 [0.005%]); vasovagal symptoms (1/30000 [0.003%]); subcutaneous induration (1/30000 [0.003%]); cold panniculitis (1/60000 [0.002%]) and hernia (1/185000 [0.001%]).

COOLSCULPTING® and the Snowflake Design are trademarks of Zeltiq Aesthetics, Inc., an AbbVie Company. ©2024 AbbVie. All rights reserved. AbbVie Pty Ltd, ABN 48 156 384 262, having its registered head office at Level 7, 241 O’Riordan Street, Mascot, NSW 2020 and trading as Allergan Aesthetics, an AbbVie Company at Level 20, 177 Pacific Hwy, North Sydney, NSW 2060. AbbVie Limited, NZBN 9429030775923, having its registered head office at Level 6, 156-158 Victoria Street, Wellington, 6011 New Zealand and trading as Allergan Aesthetics, an AbbVie Company.

CS_SNOWFLAKE_white

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE. IT DOES NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE.

AU-CSC-230026 V1, Date of Preparation: September 2024.